SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
medcases00
Published on Aug 22, 2021
A Division of Hospital Medicine Grand Rounds presented by Steven Coca, DO, MS, Associate Chair for Clinical and Translational Research, Associate Professor of Medicine (Nephrology)
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:02:49"Cardio-renal Risk Reduction Across the Spectrum of Type 2 DM" presented by Anip Bansal
12 views 610 days ago -
Watch Later
34:00 -
Watch Later
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
11 views 612 days ago -
Watch Later
!["Incidentalomas" - Evaluation and Treatment of Small Renal Masses - Reena Cherry, PA-C]()
39:51"Incidentalomas" - Evaluation and Treatment of Small Renal Masses - Reena Cherry, PA-C
13 views 1040 days ago -
Watch Later
!["Approaches to Prevent and Treat Chronic Hyperkalemia" by Edgar Lerma, MD, FACP]()
01:01:48"Approaches to Prevent and Treat Chronic Hyperkalemia" by Edgar Lerma, MD, FACP
10 views 612 days ago
